The present study aimed to immobilize TGF-β2 onto titanium implants by using a tresyl chloride-activation technique and to evaluate the bone response of TGF-β2 immobilized titanium (TGF-β2/Ti) implants in a rat femur defect model. XPS and FT-IR measurements identified the presence of TGF-β2 on titanium. Atomic force microscopy showed globular images of immobilized TGF-β2. The contact angle of TGF-β2/Ti against water significantly decreased compared with untreated titanium (Ti). There was no change of surface roughness after immobilization of TGF-β2. Ti and TGF-β2/Ti implants were inserted into rat femur defects. TGF-β2/Ti showed more bone formation by calcein labeling and histological observation. The measurements of bone to implant contact (BIC) and bone mass (BM) around the implants revealed that BIC and BM of TGF-β2/Ti implants were significantly higher than those of Ti at 4 weeks after the implantation. In conclusion, TGF-β2/Ti implant effectively enhances bone regeneration around implants.
INTRODUCTION
Titanium and titanium alloys are wildly applied as dental and orthopedic implants because of their superior mechanical properties and biocompatibility 1) . A high degree of direct contact between bone and an implant is known as osseointegration. Although osseointegration provides desirable stability to the bone tissue, titanium as a biomaterial cannot regenerate bone tissue itself and the patients are thus subject to limited mastication during wound healing for 3-6 months 2) . To accelerate and improve the bone healing process, various surface modifications of titanium dental implants including mechanical treatments such as blasting and chemical treatments such as alkali treatment or hydroxyapatite coating have been explored [3] [4] [5] [6] . In addition, biochemical treatments such as surface coating or immobilization with cell adhesive protein, fibronectin, laminin or collagen, have also been reported to be effective for enhancing osteoblastlike cell attachment, spreading, and stimulating differentiation [7] [8] [9] [10] . Hayakawa et al. 11, 12) developed an easy method to immobilize cell adhesive protein on a titanium surface, which was named the tresyl chloride-activation technique 11, 12) . This technique is a modification of the earlier method reported by Nilsson and Mosbach 13) . Tresyl chloride (2,2,2-trifluoroethanesulfonyl chloride) is a liquid that can be directly applied to the titanium surface. Titanium has two types of hydroxyl groups; a basic terminal and an acidic bridge hydroxyl group 14) . Basic hydroxyl groups at the titanium surface can directly react with tresyl chloride. Several cell adhesive proteins, such as fibronectin or collagen and fibronectin-derived peptides, could easily be immobilized onto a titanium surface using the tresyl chloride-activation technique. Quartz-crystal microbalance dissipation measurement suggested the formation of an ionic interaction between proteins and the titanium terminal hydroxyl group as shown in Fig. 1 15) . Gene expression of osteoblast-like cells was monitored on titanium immobilized with fibronectin or fibronectin-derived GRGDSP peptide and it was found that the expression levels of some genes related to the mineralization process, for example, bone sialoprotein and osteomodulin, were up-regulated 16, 17) . Yoshida et al. 18) reported that fibronectin immobilization by the tresyl chloride activation technique influenced the arrangement of attached osteoblast-like cells. Ferraris et al. 19) immobilized alkaline phosphatase onto titanium and observed a synergistic effect between biological functionalization and inorganic bioactivity. Alkaline phosphatase-immobilized titanium presented a more marked ability to induce apatite precipitation after immersion into simulated body fluid.
Growth factors, such as bone morphogenetic protein (BMP), transforming growth factor (TGF-β) and plateletderived growth factor, are known to progress bone repair, including acceleration of fracture healing 20, 21) . The most common osteogenic growth factors used for biomedical purposes are the members of the TGF-β superfamily including the BMP family. Five TGF-β isomers have been identified and three TGF-β, i.e., TGF-β1, TGF-β2 and TGF-β3, were isolated in humans and other mammals 22) . Lind et al. 23) and Nielsen et al. 24) reported that local injection of TGF-β promoted fracture healing of bone and increased callus formation.
The efficacy of TGF-β2 loading onto titanium dental implants was investigated through animal experiments. Ranieri et al. 25) and Sena et al. 26) loaded TGF-β2 onto hydroxyapatite/tricalcium phosphate coated titanium implants and placed the implants into rat femur defects. Loaded TGF-β2 stimulated bone formation around the dental implants and increased implant fixation strength. Sumner et al. 27) reported that the combined loading of TGF-β2 and BMP-2 is more useful for secure mechanical fixation of implants in dog humerus experiments.
The present study attempted to immobilize TGF-β2 onto titanium implants using the tresyl chlorideactivation technique and to evaluate the bone response of TGF-β2 immobilized titanium implants in a rat femur defect model.
MATERIAL AND METHODS

Titanium substrate
Commercially pure titanium rectangle plates (0.5 mm×1.5 mm×2.0 mm, Japan Industrial Specification H4600. 99.9 mass% Ti, Grade 2, Furuuchi Chemical Corp., Tokyo, Japan) were used after cleaning ultrasonically in acetone.
Immobilization of TGF-β2
Briefly, as-machined surface of the titanium plates were completely covered with tresyl chloride (Fluka, Buchs, Switzerland) and then were stored at 37°C for two days. Tresyl chloride was liquid and directly applied without any dilution. Tresylated titanium disks were washed with acetone followed by water, water-acetone solution(50 : 50), then were dried and stored in a desiccator.
Recombinant human TGF-β2 (rhTGF-β2, SIGMA-ALDRICH, St. Louis, USA) was dissolved in doubledistilled water at concentration of 1 μg/mL. The surface of each tresylated titanium plate was completely covered dropwise with rhTGF-β2 solution, and the plates were stored at 37°C for 24 h. After rinsing with double-distilled water, the titanium plates were dried with a gentle stream of dry air and stored in a desiccator at room temperature. In this way, TGF-β2 immobilized titanium (TGF-β2/Ti) could be obtained. Untreated titanium (Ti) plates were used as a control.
Surface characterization
Surface analysis after TGF-β2 immobilization was performed using an X-ray photoelectron spectroscope (XPS, ESCA-3400, Shimadzu Corp, Kyoto, Japan) equipped with a MgKα X-ray source operated at 10 kV and 20 mA. Immobilization of TGF-β2 was confirmed by the N1s peak of amide bonds of TGF-β2. The binding energy of each spectrum was calibrated against the C1s peak at 284.8 eV.
The surface of TGF-β2/Ti was also examined using Fourier transform infrared spectroscopy (FT-IR, FTIR-8300, Shimadzu Corp., Kyoto, Japan) with the attenuated total reflection method. The measurement of FT-IR was performed under a nitrogen atmosphere.
Atomic force microscopy observation
The topography of the TGF-β2/Ti surface was examined by easyScan 2 FlexAFM, (Nanosurf AG, Switzerland). Scans were made in contact mode using a monolithic silicone probe coated with aluminum (ContAl-G, BudgetSensors, Innovative Solutions Bulgaria Ltd. Bulgaria). The typical scan size was 2×2 μm 2 . The untreated Ti surface was also examined.
Contact angle and surface roughness measurements
Static water contact angles were determined by depositing a droplet of double-distilled water on the surface using a Contact Angle Meter (CA-D, Kyowa Interface Science, Tokyo, Japan). Three measurements of 15 s each were made and all analyses were performed at the same temperature and humidity. The surface roughnesses (Ra) of TGF-β2-immobilized and untreated control titanium plates were measured with a Handysurf E-30A (Tokyo Seimitsu Co., Ltd., Tokyo, Japan) with a scan length of 4 mm and a cut-off value of 0.8.
Animal experiment
Animal experiments were reviewed and approved by the Institutional Animal Care Committee of Tsurumi University School of Dental Medicine (Certificate Number: 24A001). A total of sixteen 6-week-old male Wistar rats weighing 180-200 g were used. They were given free access to standard rat-chow and water. All animals were housed in a temperature-controlled room with a 12 h alternating light-dark cycle and were given water and food ad libitum during the experimental period.
Each animal received one implant. A total of sixteen implants were inserted, namely, four Ti and four TGF-β2/Ti implants for 2 weeks, and four Ti and four TGF-β2 /Ti implants for 4 weeks. Before the animal experiments, all plates were sterilized using ethylene oxide gas.
The implantation surgery was performed under general inhalation anesthesia with a 4% isoflurane and oxygen mixture, which was reduced to 2% isoflurane during surgical manipulation. Local anesthesia was performed by an injection of xylocaine. The right hind limb was shaved after sterilization with ethanol. A longitudinal incision was made on the distal surface of the right hind limb to expose the femur. A cortical bone defect measuring 0.8×1.5 mm was created through the cortex and the medulla. The bone defect was prepared with a very gentle surgical technique and continuous internal cooling with physiological saline solution.
After insertion of the implants into the bone defects, muscle tissue and skin were closed in separate layers by single-knot technique (BioFit-D 5-0, WASHIESU MEDICAL, Japan, Nylon 4-0, MANI, JAPAN). To reduce the risk of perioperative infection, a prophylactic antibiotic equivalent to latamoxef sodium (0.01 mg/kg Shiomalin, SHIONOGI, Osaka, Japan) was administered postoperatively by subcutaneous injection.
The bone labeling was performed by fluorochrome administration. All rats were injected with 5 mg/ kg calcein (Dojindo, Tokyo, Japan) by subcutaneous infusion at 7 days before sacrifice, namely at 7 days after implantation for the 2 weeks groups and at 21 days after implantation for 4 weeks groups, respectively. Then 30 mg/kg alizarin red S (SIGMA-ALDRICH, Japan) was injected 1 day before sacrifice, namely at 13 days after implantation for the 2 weeks groups and at 27 days after implantation for the 4 weeks groups, respectively. The animals were sacrificed at 2 and 4 weeks after implantation. The femurs were harvested and fixed in 10% neutralized formalin for histological observation.
Histology
The fixed specimens were dehydrated through graded series of ethanol and embedded into methylmethacrylate.
After polymerization, nondecalcified thin sections were prepared using a cuttinggrinding technique (EXAKT-Cutting Grinding System, BS-300CP band system & 400 CS microgrinding system, EXAKT) 28) . Sections of approximately 50-70 μm were made in a transverse direction perpendicular to the long axis of implants.
Before staining the sections, a confocal laser scanning microscope (CLSM, TCS Multi-Photon, Leica, Germany) photograph was taken. As alizarin red labeling was indistinct in this study, calcein labeling was used for the quantitation of new bone formation. Regions of interest (ROI) for quantitative analysis were determined as illustrated in Fig. 2 .
After CLSM observation, undecalcified sections were stained with methylene blue and basic fuchsin and were evaluated using a light microscope (BX51, OLYMPUS, Tokyo, Japan, magnification 200×).
Histomorphometrical analysis
Histomorphometrical analysis of the percentage of bone to implant contact (BIC) and bone mass (BM) around the implants was evaluated using an image analysis system (WinROOF, Visual System Division, Mitani Corporation, Tokyo, Japan). BIC was calculated as the percentage of the length of bone-implant contact within the ROI. Bone volume was defined as the percentage of newly formed bone within the ROI.
Statistical analysis
The results from histomorphometrical measurements were evaluated by one-way analysis of variance (ANOVA) using Origin Pro 8J (OriginLab Corp., MA, USA) and the Bonferroni test for multiple comparisons among means at p<0.05. The obtained values are represented as mean±standard deviation.
RESULTS
Surface characterization
The surface of TGF-β2/Ti was examined using XPS and FT-IR. Wide and narrow scans of XPS are shown in Figs. 3 and 4 . The N1s peak, derived from the amide bond of immobilized TGF-β2, was detected at 399.9 eV on TGF-β2/Ti, but not on the Ti surface. The Ti2 P peak could be detected on both TGF-β2/Ti and Ti surface. The results indicated that the entire titanium surface was not completely covered with TGF-β2.
The FT-IR spectrum of TGF-β2/Ti is shown in Fig.  5 . Peaks at around 1,450-1,550 cm −1 and 1,600-1,800 cm −1 derived from the amide group of immobilized TGF-β2 were identified.
AFM images of titanium and TGF-β2/Ti are shown in Fig. 6 . Globular images of TGF-β2 could be observed on the TGF-β2/Ti surface. Table 1 shows the contact angle and Ra data for Ti and TGF-β2/Ti. The contact angle of TGF-β2/Ti significantly decreased compared with Ti (p<0.05). Ra values were almost the same between Ti and TGF-β2/ Ti.
Fluorescent labeling
Typical CLSM images of Ti and TGF-β2/Ti implants at 2 and 4 weeks after the implantation are shown in Figs. 7 and 8, respectively. Denser green labeling in the bone around the implant could be observed for the TGF-β2i/ Ti implant, while the levels of densities of green labeling between 2 and 4 weeks appeared to be almost the same for both Ti and TGF-β2i/Ti samples.
As green fluorochrome labeling due to calcein administration was more clearly visible than alizarin red labeling, we assessed new bone formation by the total length of calcein labeling in the ROI. The results are shown in Fig. 9 . There were no significant differences in calcein labeling length between Ti and TGF-β2/ Ti implants at 2 and 4 weeks after the implantation (p>0.05). Calcein labeling length did not significantly change from 2 weeks to 4 weeks for both Ti and TGF-β2/ Ti implants (p>0.05).
Histological evaluation
The histological appearances of bone formation around Ti and TGF-β2/Ti implants at 2 weeks after implantation are shown in Fig. 10 . No signs of an inflammatory response were detected in the tissue surrounding the implants. The bone responses to Ti and TGF-β2/Ti implants at 2 weeks were different. More close contact of bone formation towards TGF-β2 could be identified. The histological appearances 4 weeks after implantation are shown in Fig. 11 . At 4 weeks, more mature bone formation was recognized, and bone remodeling was still proceeding. TGF-β2/Ti implants showed more bone formation than Ti implants.
The results of the measurements of BIC are shown in Fig. 12 . There was no significant difference in BIC at 2 weeks between Ti and TGF-β2/Ti implants (p>0.05). At 4 weeks, the BIC of TGF-β2/Ti implants was significantly higher than that for Ti (p<0.05). Comparing 2 and 4 weeks, BIC at 4 weeks significantly increased compared that at 2 weeks for both Ti and TGF-β2/Ti implants (p<0.05).
Figure13 shows the results of measurements of BM. At 2 weeks, no significant difference was noted between Ti and TGF-β2/Ti implants (p>0.05). At 4 weeks, BM of TGF-β2/Ti implants was significantly greater than that for Ti (p<0.05). Comparing 2 and 4 weeks, BM at 4 weeks was significantly higher than that at 2 weeks for both Ti and TGF-β2/Ti implants (p<0.05).
DISCUSSION
In the study, we immobilized TGF-β2 onto titanium implants by using the tresyl chloride-activation technique and evaluated the bone response of TGF-β2/ Ti implants in a rat femur defect model. TGF-β2 could be easily immobilized onto titanium by using the tesyl chloride-activation technique and enhancement of bone formation was recognized with TGF-β2/Ti. For the immobilization of proteins onto titanium, silane coupling agents have been widely employed [29] [30] [31] [32] . However, the use of silane coupling agents requires multiple steps of treatment, for example, acidic pretreatment of the titanium surface and a condensation reaction between silane coupling agents and proteins. The unreacted silane coupling agents must remove during the cleaning steps because of their adverse physiological effects.
The advantage of tresyl chloride-activation technique is its easiness. There is no need for any pretreatment of the titanium surface, such as passive oxidation or alkaline treatment, and no need for any special apparatus. Another advantage of the tresyl chloride-activation technique is that many types of proteins and growth factors can be immobilized on the titanium surface.
TGF-β is a well-known osteogenic growth factor. TGF-β transgenic and knockout experiments indicated that TGF-βs are multifunctional genes, and while the anabolic effects of TGF-β1 and TGF-β2 on skeletal tissues appear to be similar, TGF-β3 has an inhibitory function 33, 34) . The anabolic effects of TGF-β on bone formation were demonstrated by injecting TGF-β1 or TGF-β2 under the periosteum [35] [36] [37] . In addition, systemic administration of TGF-β2 increased the rate of bone formation and mineral apposition 38) . Using implantation experiments into the rat femur bone defects, Ranieri et al. 25) studied the influence of loading TGF-β2 to hydroxyapatite/tricalcium phosphate coated titanium implants on bone response, and reported that 10 μg rhTGF-β2 loading increased bone regeneration, but a lower dose was not effective. In contrast, Sena et al. 26) evaluated the doses of rhTGF-β2 at 5, 10 and 20 μg for bone response after implantation into rat femur defects and found that all rhTGF-β2 groups provided significantly higher bone volume. However, regarding bone-implant contact, the 20 μg dose group had less contact than the control, and all rhTGF-β2 groups showed decreased fixation strength of implants compared with the control. TGF-β is also known to inhibit mineralization as demonstrated by the inhibitory effect on mineralization in primary osteoblasts and bone organ culture when continuously treated with TGF-β 39, 40) . Moreover, it has been reported that TGF-β injections must be discontinued for mineralized bone to form in animal models of TGF-β-induced bone formation 41) . Thus it is predicted that the amount of TGF-β will influence the bone response.
In the present study, the immobilized amounts of TGF-β2 were unknown. Pudgee et al. 16) quantified the amounts of fibronectin immobilized onto titanium when using the tresyl chloride-activation technique. They found that if they used 100 µg/mL of fibronectin solution, 277.5 ng of fibronectin was immobilized onto titanium. The present study used 1 μg/mL of TGF-β2 solution. Thus, we predicted that the immobilized amounts of TGF-β2 would be only a few ng although the applied amounts of protein solution and the molecular weight of proteins are different, i.e., 440 kDa for fibronectin and 25 kDa for TGF-β2 42) . Since the release of TGF-β2 after the implantation was not monitored in the present study, the local concentrations of TGF-β2 around the implants are unknown. Ferraris et al. 19) reported when using the tresyl chloride-activation technique that significant amounts of immobilized alkaline phosphatase were removed by washing with Tris buffered solution. It is presumed that the lower concentration of TGF-β2 released from the surfaces of TGF-β2/Ti implants in vivo and TGF-β2/Ti implants might have stimulated bone formation around them in the present study. The influence of the immobilized and released amounts of TGF-β2 on the bone response should be further investigated in detail.
Immobilization of TGF-β2 onto titanium did not change the surface roughness but changed the hydrophilicity of the surface. Some reports insist that surface hydrophilicity is an important factor for the achievement of osseointegration 4, 43) . Thus, the hydrophilic surface of TGF-β2/Ti is also effective for enhancing bone formation.
Fluorescent dyes chelate to calcium ions, resulting in deposition of a multiple vital label on all actively mineralizing bone surfaces 44) . The present calcein administration provided clear green fluorochrome labeling and also provided evidence of early bone formation during the healing process around the TGF-β2/Ti implants. However, labeling by alizarin red could not be clearly recognized. It is presumed that the administered dose was insufficient for bone labeling. Administration of a higher dose of alizarin red or another appropriate labeling agent should be attempted in additional experiments. For human clinical application of TGF-β2/Ti implant, evaluation using larger animal such as dog will be further conducted with the consideration of animal welfare.
In conclusion, it is clear that the TGF-β2/Ti implant is effective for enhancement of bone regeneration around implants. It is reported that combined use of TGF-β2 and BMP led to more secure fixation of the implant than the use of either growth factor alone in canine experiments 27) . The combined immobilization of TGF-β2 and BMP or other growth factors will be further investigated in future.
